TVTX stock forecast for 2023 – 2027

Are you interested in Travere Therapeutics, Inc. stocks prediction? If yes, then on this page you will find useful information about the dynamics of the TVTX stock price in 2022-2027. Is TVTX a good long term stock? When should I take profit in Travere Therapeutics stock? Buy or sell stock? Will TVTX stock price go up? What are analysts’ forecasts for TVTX stock?
Forecst.com predicts future values using technical analysis of a large number of analytical parameters. TVTX stock returns are also predicted based on historical data.

According to our research, TVTX stock is a good long-term investment. TVTX share price has been in a bull cycle for the past year. Travere Therapeutics, Inc. stock trend is positive.

Travere Therapeutics company info

Industry Biotechnology
Address 3611 Valley Centre Drive, San Diego, CA, 92130, United States
Website https://www.travere.com

Forecasting

52 Week High: 31.1885 USD
52 Week Low: 25.5329 USD
1 Year Forecast: 30.4643 USD
5 Year Forecast: 45.4357 USD

Agilent Technologies info

Market Cap: 1.62B
52 Week Change: -3.215%
52 Week High: 33.09 USD
52 Week Low: 12.75 USD
Beta: 0.841922
50 Day Moving Average: 28.29
90 Day Moving Average: 28.619
200 Day Moving Average: 24.37
Resistance Level: 29.0779
Pivot Point: 27.3666
Support Level: 24.56
Enterprise Value: 0
Forward P/E: 0
Forward EPS: 0
Profit Margin: 0
Shares Outstanding: 0
EBITDA: 0
Held Percent Institutions: 0
PEG Ratio (5Y): 0
Trailing EPS: 0

Travere Therapeutics stock forecasts for 2023-2027

DateOpen PriceClose PriceChange

Travere Therapeutics Stock Forecast for 2023

January 2023 31.31 30.6 -2.27%
February 2023 30.6 31 1.31%
March 2023 30.38 30 -1.25%
April 2023 30.3 30 -0.99%
May 2023 29.4 29.7 1.02%
June 2023 30.3 31.62 4.36%
July 2023 31.62 31.62 0%
August 2023 31.31 31.36 0.16%
September 2023 32.32 34.68 7.3%
October 2023 34.68 34 -1.96%
November 2023 34.68 35.35 1.93%
December 2023 34.3 35.7 4.08%

Travere Therapeutics Stock Forecast for 2024

January 2024 35 34.68 -0.91%
February 2024 34.34 35 1.92%
March 2024 35.35 33.66 -4.78%
April 2024 34.34 33.66 -1.98%
May 2024 33.66 33.66 0%
June 2024 33.33 34.34 3.03%
July 2024 34.65 34.3 -1.01%
August 2024 35.35 36.36 2.86%
September 2024 35.28 37.62 6.63%
October 2024 38.76 37.37 -3.59%
November 2024 36.63 37.62 2.7%
December 2024 38 39.39 3.66%

Travere Therapeutics Stock Forecast for 2025

January 2025 39.39 38.38 -2.56%
February 2025 37.24 38.22 2.63%
March 2025 38.61 36.63 -5.13%
April 2025 36.63 38 3.74%
May 2025 37 36.26 -2%
June 2025 37.74 37.62 -0.32%
July 2025 37.24 38.76 4.08%
August 2025 38.38 38.22 -0.42%
September 2025 40.8 41.41 1.5%
October 2025 41 41 0%
November 2025 40.18 42.42 5.57%
December 2025 42.84 42.57 -0.63%

Travere Therapeutics Stock Forecast for 2026

January 2026 43.43 42 -3.29%
February 2026 42 43 2.38%
March 2026 43.43 41.82 -3.71%
April 2026 41.41 40.18 -2.97%
May 2026 40.18 41.41 3.06%
June 2026 41.41 42.84 3.45%
July 2026 42.42 41.58 -1.98%
August 2026 42 43.43 3.4%
September 2026 43.43 45.9 5.69%
October 2026 44.55 45.45 2.02%
November 2026 45.45 45.08 -0.81%
December 2026 46.46 45.54 -1.98%

Travere Therapeutics Stock Forecast for 2027

January 2027 46.92 46.46 -0.98%

Other companies stock forecasts